Myriad can patent breast cancer genes: court
Myriad can patent breast cancer genes: court
CHICAGO (Reuters) – A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.